Pharmanutra SpA (PHN) NPV

Sell:€54.00Buy:€56.30€0.90 (1.63%)

Prices delayed by at least 15 minutes
Sell:€54.00
Buy:€56.30
Change:€0.90 (1.63%)
Prices delayed by at least 15 minutes
Sell:€54.00
Buy:€56.30
Change:€0.90 (1.63%)
Prices delayed by at least 15 minutes

Company Information

About this company

Pharmanutra SpA is an Italy-based company engaged in the healthcare industry. The Company develops nutraceutical products and medical devices. It focuses on studying and producing formulations that are backed up in scientific research. It is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The Company offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Key people

Andrea Lacorte
Executive Chairman of the Board
Roberto Lacorte
Executive Vice Chairman of the Board
Carlo Volpi
Chief Marketing Officer, Executive Director
Germano Tarantino
Executive Director
Alessandro Calzolari
Lead Independent Non-Executive Director
Marida Zaffaroni
Independent Non-Executive Director
Giovanna Zanotti
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Italy
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    IT0005274094
  • Market cap
    €533.42m
  • Employees
    119
  • Shares in issue
    9.68m
  • Exchange
    Italian SE (Mercato Continuo Italia)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.